BIO Brings Lawton In-House As VP-Reg Affairs/Counsel: PDUFA III Looms

Biotechnology Industry Organization VP-Regulatory Affairs Stephan Lawton will focus on the reauthorization of the Prescription Drug User Fee Act upon joining the association on Jan. 1, 2001.